View Post

Killing ‘Sleeper Cells’ May Prevent Relapse in ER+ Breast Cancer Therapy

In Clinical Studies News by Barbara Jacoby

By: Alana Hippensteele, Editor From: The anti-cancer medicine venetoclax may improve the current therapy for estrogen receptor-positive (ER+) breast cancer, according to preclinical studies.1 Led by Walter and Eliza Hall Institute researchers, the new study used breast cancer cells taken from patients and demonstrated that venetoclax was effectively able to kill sleeping, or ‘senescent,’ cancer cells.1 The results from …